IGM Biosciences Reaches Analyst Target Price
December 16, 2019 at 09:15 AM EST
In recent trading, shares of IGM Biosciences Inc (IGMS) have crossed above the average analyst 12-month target price of $28.25, changing hands for $29.08/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..